 congenit anomali children patient chemotherapi cancer childhood adolesc background mani patient childhood cancer regimen mutagen chemotherapeut agent treatment childhood adolesc children method effect chemotherapi cancer childhood adolesc outcom subsequ pregnanc record men women pediatr cancer questionnair patient pregnanc patient chemotherapi part treatment cancer patient wive patient pregnanc week gestat former patient total live-born stillborn children result frequenc congenit anomali percent live-born children women percent live-born children men structur congenit cardiac defect percent children women dactinomycin percent children multicent survey fetal anomali relat number mutagen cumul dose agent frequenc congenit anomali children conclus data treatment children adolesc mutagen chemotherapeut agent dose frequenc congenit anomali children former patient possibl advers effect dactinomycin children patient studi